# Ernexa Therapeutics Inc.: Form 8-K, filed Nov 22, 2013

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2013-11-22
- Accepted by EDGAR: Nov 22, 2013, 14:44 ET
- Period: 2013-11-22
- Accession: 0001019687-13-004605
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000101968713004605/ntn_8k-112213.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000101968713004605/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000101968713004605/ntn_8k-112213.htm

Filed Nov 22, 2013.
Source: SEC EDGAR, the filing index for accession 0001019687-13-004605. Last ingested by Listed: Nov 11, 2026, 02:49 ET. No prices; not investment advice.
